AVIR Latest Press Releases

-- November 2, 2026 --

Atea Pharmaceuticals to Host Third Quarter 2026 Financial Results and Business Update Conference Call on November 9, 2026 Globe Newswire 4:05 PM

-- September 8, 2026 --

Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference Globe Newswire 7:00 AM

-- August 12, 2026 --

Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- August 5, 2026 --

Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026 Globe Newswire 7:00 AM

-- July 28, 2026 --

Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus Globe Newswire 7:00 AM

-- July 14, 2026 --

Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus Globe Newswire 7:00 AM

-- June 25, 2026 --

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes